Vancomycin-Induced Organizing Pneumonia: A Case Report and Literature Review

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2021 Jul 2

PMID 34208316

Authors

Young-Shin Lee

Yu-Mi Lee

Affiliations

Soon will be listed here.

Abstract

The long-term administration of vancomycin has increased; however, the pulmonary adverse reactions of long-term vancomycin treatment remain under-studied. A 75-year-old male patient with vertebral osteomyelitis receiving long-term vancomycin therapy developed a fever. High resolution computed tomography showed irregular ground glass opacity and consolidation in the right upper lung. The patient developed organizing pneumonia. This occurred without peripheral eosinophilia or adverse reactions in the skin and liver. The administration of vancomycin was discontinued. He recovered from organizing pneumonia after four weeks of steroid therapy. Solitary organizing pneumonia can develop during treatment with vancomycin. When pulmonary inflammation occurs and other causes of pneumonia are excluded, vancomycin therapy should be discontinued.

References

Hewitson L . Vancomycin induced DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) in a patient with tricuspid endocarditis. BMJ Case Rep. 2019; 12(9). PMC: 6754717. DOI: 10.1136/bcr-2019-229590. View

Issa K, Diebo B, Faloon M, Naziri Q, Pourtaheri S, Paulino C . The Epidemiology of Vertebral Osteomyelitis in the United States From 1998 to 2013. Clin Spine Surg. 2017; 31(2):E102-E108. DOI: 10.1097/BSD.0000000000000597. View

Boet S, Noblet C, Haas-Hubscher C, Picard D, Musette P, Dureuil B . Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock. Eur J Anaesthesiol. 2009; 26(9):791-3. DOI: 10.1097/EJA.0b013e32832ac3a6. View

Isono T, Sawaguchi H, Kusumoto H, Shiono H . Eosinophilic Pneumonia Putatively Induced by Vancomycin: A Case Report. Am J Case Rep. 2019; 20:1440-1445. PMC: 6788487. DOI: 10.12659/AJCR.917647. View

Bruniera F, Ferreira F, Saviolli L, Bacci M, Feder D, da Luz Goncalves Pedreira M . The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015; 19(4):694-700. View

Cordier J . Organising pneumonia. Thorax. 2000; 55(4):318-28. PMC: 1745738. DOI: 10.1136/thorax.55.4.318. View

Miyazu D, Kodama N, Yamashita D, Tanaka H, Inoue S, Imakyure O . DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report. Am J Case Rep. 2016; 17:625-31. PMC: 5012458. DOI: 10.12659/ajcr.899149. View

OMeara P, Borici-Mazi R, Morton A, Ellis A . DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin. Allergy Asthma Clin Immunol. 2011; 7:16. PMC: 3198947. DOI: 10.1186/1710-1492-7-16. View

Madigan L, Fox L . Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol. 2019; 81(1):123-128. DOI: 10.1016/j.jaad.2019.02.002. View

10.

Kwon H, Chang Y, Jeong Y, Lee S, Song W, Kim H . A case of hypersensitivity syndrome to both vancomycin and teicoplanin. J Korean Med Sci. 2006; 21(6):1108-10. PMC: 2721938. DOI: 10.3346/jkms.2006.21.6.1108. View

11.

Cobb E, Kimbrough R, Nugent K, Phy M . Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin. Ann Pharmacother. 2007; 41(4):696-701. DOI: 10.1345/aph.1H372. View

12.

Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, Masugi Y . The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol. 1987; 126(1):171-82. PMC: 1899540. View

13.

Wilcox O, Hassanein M, Armstrong J, Kassis N . Case report: atypical presentation of vancomycin induced DRESS syndrome: a case report and review of the literature. BMC Pulm Med. 2017; 17(1):217. PMC: 5745618. DOI: 10.1186/s12890-017-0564-6. View